A5060396380- Medical Imaging Techniques and Applications
- Prostate Cancer Treatment and Research
- Radiopharmaceutical Chemistry and Applications
- Prostate Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Neuroendocrine Tumor Research Advances
- Neuroblastoma Research and Treatments
- Lymphoma Diagnosis and Treatment
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Sarcoma Diagnosis and Treatment
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Multiple Myeloma Research and Treatments
- Peptidase Inhibition and Analysis
- Lung Cancer Diagnosis and Treatment
- CAR-T cell therapy research
- Hepatocellular Carcinoma Treatment and Prognosis
- Urologic and reproductive health conditions
- Cardiac Imaging and Diagnostics
- Pancreatic and Hepatic Oncology Research
- Ovarian cancer diagnosis and treatment
- Cancer Research and Treatments
- Endometrial and Cervical Cancer Treatments
Policlinico S.Orsola-Malpighi
2016-2025
Istituto delle Scienze Neurologiche di Bologna
2022-2025
Azienda USL di Bologna
2009-2025
University of Bologna
2016-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2021-2025
European Institute of Oncology
2023
University College London
2022
The Royal Free Hospital
2022
Ospedale Regionale di Bellinzona e Valli
2022
University of Ulster
2022
In advanced prostate cancer (APC), successful drug development as well advances in imaging and molecular characterisation have resulted multiple areas where there is lack of evidence or low level evidence. The Advanced Prostate Cancer Consensus Conference (APCCC) 2017 addressed some these topics. To present the report APCCC 2017. Ten important controversy APC management were identified: high-risk localised locally cancer; “oligometastatic” castration-naïve castration-resistant role APC;...
In prostate cancer with biochemical failure after therapy, current imaging techniques have a low detection rate at the prostate-specific antigen (PSA) levels which targeted salvage therapy is effective. <sup>11</sup>C-choline and <sup>18</sup>F-fluoromethylcholine, though widely used, poor sensitivity PSA levels. <sup>68</sup>Ga-PSMA (Glu-NH-CO-NH-Lys-(Ahx)-[<sup>68</sup>Ga-<i>N,N</i>′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-<i>N,N</i>′-diacetic acid]) has shown promising...
Contrast-enhanced computed tomography (CT) of the neck-thorax-abdomen and pelvis, including 3-phase examination liver, constitutes basic imaging for primary neuroendocrine tumor (NET) diagnosis, staging, surveillance, therapy monitoring. CT characterization lymph nodes is difficult because inadequate size criteria (short axis diameter), bone metastases are often missed. magnetic resonance (MRI) diffusion-weighted preferred pancreas, brain bone. MRI may miss small lung metastases. less well...
Background and Objectives Bone lesions in multiple myeloma (MM) have been traditionally detected by whole body X-ray (WBXR) survey although magnetic resonance imaging (MRI) has become the gold standard for detecting MM involvement of spine pelvis. The aim this study was to compare a new technique, positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) integrated computed (18F-FDG PET-CT), MRI WBXR baseline assessment bone disease MM.Design Methods We prospectively compared...
Innovations in treatments, imaging, and molecular characterisation advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some these topics supplement guidelines based on level 1 evidence.To present the results from APCCC 2019.Similar prior conferences, experts identified 10 important areas controversy regarding cancer:...
The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert Panel identified and reviewed the available evidence for ten most important areas of controversy in advanced prostate cancer (APC) management. successful registration several drugs castration-resistant recent studies chemo-hormonal therapy men with castration-naïve have led to considerable uncertainty as best treatment choices, sequence options appropriate patient selection. Management recommendations based on...
Abstract Rationale The development of consensus guidelines for interpretation Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide more consistent reports in clinical practice. standardization PSMA-PET may also contribute increasing the data reproducibility within trials. Finally, are communicate exact location findings referring physicians, support clinician therapeutic management decisions. Methods A panel worldwide experts was established....
Comparative reviews of whole-body magnetic resonance imaging (WB-MRI) and positron emission tomography/computed tomography (CT; with different radiotracers) have shown that metastasis detection in advanced cancers is more accurate than currently used CT bone scans. However, the ability WB-MRI tomography/CT to assess therapeutic benefits has not been comprehensively evaluated. There also considerable variability availability quality WB-MRI, which an impediment clinical development. Expert...